Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-08-22

FDA Approved: TRIUMEQ — Original Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved Triumeq (abacavir sulfate, dolutegravir sodium, lamivudine) through its original application; it is a fixed-dose combination antiretroviral therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triumeq (dolutegravir/abacavir/lamivudine)

Snippet

ORIG AP for TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)